U.S. Pharma Stock News

NasdaqGS:HBAN
NasdaqGS:HBANBanks

Is Huntington Bancshares (HBAN) Attractively Priced After Recent Share Price Weakness

If you are wondering whether Huntington Bancshares is attractively priced today, the key question is how its current share price compares with a fair value estimate. The stock last closed at US$15.48, with returns of 12.6% over 1 year and 59.5% over 3 years, although the past week, month, and year to date have seen declines of 7.2%, 16.6%, and 11.4% respectively. Recent market attention around Huntington Bancshares has centered on its position among U.S. regional banks and how investors view...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

A Look At Aeva Technologies (AEVA) Valuation After Recent Share Price Volatility

Aeva Technologies (AEVA) has been drawing attention after recent share price moves, with the stock showing a mix of short term swings and longer term gains that prompt fresh questions around growth, losses and valuation. See our latest analysis for Aeva Technologies. The latest pullback, with a 1 day share price return of 8.44% decline to US$15.30, comes after a 30 day share price return of 18.24% and a very large 1 year total shareholder return that suggests momentum has been strong despite...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Does Granahan’s Exit Test SPS Commerce’s (SPSC) Long-Running Growth Narrative?

In the past few days, Granahan Investment Management disclosed a major reduction in its SPS Commerce stake, selling 368,776 shares for about US$34.19 million. This comes as SPS Commerce records its 100th consecutive quarter of revenue growth, underscoring persistent topline momentum alongside portfolio reshuffling by a large shareholder. Now we’ll examine how Granahan’s sizable share sale intersects with SPS Commerce’s ongoing operating growth to reshape its investment narrative. We've...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Is Shopify (SHOP) Pricing Outrun By Growth Hopes After Recent Competitive Headlines?

If you are wondering whether Shopify's current share price reflects its long term potential, you are not alone. This article will help you frame that question clearly before you make any decisions. Shopify's stock closed at US$126.17, with returns of a 6.4% decline over the last 7 days, a 0.8% decline over 30 days, a 19.7% decline year to date, but gains of 39.3% over 1 year and 182.4% over 3 years, while the 5 year return sits at 12.9%. Recent price moves have been in the spotlight as...
NYSE:EXP
NYSE:EXPBasic Materials

Assessing Eagle Materials (EXP) Valuation After Recent Share Price Weakness

Eagle Materials (EXP) has been under pressure recently, with the stock showing declines over the past week, month, and past 3 months. That pullback is prompting closer attention to the company’s current fundamentals. See our latest analysis for Eagle Materials. At a share price of US$186.43, Eagle Materials has seen recent momentum fade, with a 30-day share price return of 19.04% and a 1-year total shareholder return of 9.73%, while the 3 and 5-year total shareholder returns of 39.28% and...
NasdaqGS:JCAP
NasdaqGS:JCAPConsumer Finance

Is It Time To Reassess Jefferson Capital (JCAP) After The Recent Share Price Pullback

If you are looking at Jefferson Capital and wondering whether the recent price offers value or a value trap, you will want to see how the current share price stacks up against a few different valuation checks. The stock last closed at US$20.36, with returns of a 6.4% decline over 7 days, a 9.4% decline over 30 days and a 7.9% decline year to date, which can change how investors think about both its potential upside and its risk. Recent coverage around Jefferson Capital has focused on its...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Is It Time To Revisit Array Technologies (ARRY) After Recent Share Price Pullback

If you are wondering whether Array Technologies is starting to look like value at around US$6.80 per share, you are not alone. That question sits at the heart of this review. The stock has had a mixed run, with a 4.8% decline over the last 7 days, a sharper 41.4% decline over the last 30 days and a 29.8% decline year to date. Yet it still shows a 12.2% return over the last 1 year against much larger pullbacks of 61.8% over 3 years and 77.1% over 5 years. Recent coverage of Array Technologies...
NYSE:AM
NYSE:AMOil and Gas

How Investors May Respond To Antero Midstream (AM) Beating Q4 Estimates And Selling Utica Assets

Antero Midstream recently reported past fourth-quarter 2025 earnings that exceeded analyst expectations and completed the US$400,000,000 sale of its Utica Shale midstream assets to affiliates of Natural Resources, Inc. and Northern Oil and Gas, Inc. Alongside this, Senior Vice President and Chief Accounting Officer Sheri Pearce sold 14,000 shares, offering investors additional context on insider activity and capital allocation following the asset sale. With the Utica Shale asset sale now...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

AI Push and Global Expansion Might Change The Case For Investing In Chefs' Warehouse (CHEF)

Recently, The Chefs’ Warehouse outlined its resilience plan amid economic and geopolitical uncertainty, highlighting ongoing integration of Hardie’s, facility expansions in Texas and the Middle East, and efforts to improve supply chain reliability. The company also underscored increasing use of AI and digital tools to sharpen sales execution and enhance the ordering experience for its restaurant customers. Next, we’ll examine how this push into AI-driven sales tools and operational expansion...
NYSE:DEC
NYSE:DECOil and Gas

Is Diversified Energy (DEC) Pricing Reflecting Recent 32% Annual Gain And DCF Implied Upside

Wondering if Diversified Energy is priced fairly today, or if the market is missing something that you can still take advantage of? The shares last closed at US$14.44, with returns of 9.5% over the past 30 days and 32.0% over the past year. However, the 3-year and 5-year returns of negative 23.0% and negative 47.6% show a much tougher longer term picture. Recent coverage around Diversified Energy has focused on its position in the US energy sector and how its business model responds to...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Radware (RDWR) Valuation Check After Launch Of New Cloud Web DDoS Protection Service

Radware (NasdaqGS:RDWR) is drawing fresh attention after launching a cloud-based Web DDoS Protection service for encrypted traffic. The service is designed to block sophisticated layer 7 attacks without SSL certificate sharing or traffic decryption. See our latest analysis for Radware. That product launch comes as Radware’s share price sits at US$25.6, with a 90 day share price return of 7.74% and a 1 year total shareholder return of 21.96%. This suggests momentum has been building over the...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart Bank Charter Plan Puts Valuation And Funding Model In Focus

Upstart Holdings (NasdaqGS:UPST) plans to apply for a US national bank charter, establishing Upstart Bank, N.A. The company intends to file applications with the OCC and FDIC, and seek Federal Reserve approval to become a bank holding company. The move would position Upstart to operate as an insured national bank with direct access to consumer deposits. For investors tracking NasdaqGS:UPST, this banking push comes after a difficult stretch for the stock. Shares recently closed at $25.76,...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

Red Rock Resorts (RRR) Valuation Check After Q4 Earnings Beat And New Cash Dividend

Red Rock Resorts (RRR) shares are in focus after the company exceeded fourth-quarter 2025 earnings and revenue estimates, and its board approved a cash dividend of $0.26 per share. See our latest analysis for Red Rock Resorts. Despite a recent soft patch, with a 30 day share price return of a 13.6% decline and an 8.4% decline year to date at US$57.71, Red Rock Resorts still carries a 1 year total shareholder return of 42.9% and a 5 year total shareholder return of 110.7%. This suggests longer...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Natera Launches Zenith Genomics To Expand Rare Disease Testing Story

Natera (NasdaqGS:NTRA) has launched Zenith Genomics, a next generation whole genome sequencing assay for rare disease detection. The assay is being introduced in partnership with MyOme, with exclusive collaboration around genome wide rare disease diagnostics. Zenith Genomics integrates advanced methylation analysis with DNA sequencing to address difficult diagnostic questions in rare conditions. The launch and supporting data are being presented at a leading medical genetics conference,...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Assessing Whether Black Hills (BKH) Shares Look Undervalued After Recent Pullback

With no single headline event driving attention today, Black Hills (BKH) is drawing interest as investors reassess this regulated electric and natural gas utility company’s recent share performance and fundamental profile. See our latest analysis for Black Hills. At a share price of US$70.65, Black Hills has had a soft patch recently, with a 7 day share price return of negative 4.9% and a 30 day share price return of negative 2.4%. However, its 1 year total shareholder return of 24.2% points...
NYSE:PII
NYSE:PIILeisure

Is Polaris (PII) Using the Indian Brand Sale to Quietly Redraw Its Core Identity?

Polaris recently gained attention as Wells Fargo began covering the stock with an Equal-Weight rating, while the company also confirmed plans to sell its Indian motorcycle brand to Carolwood in the first quarter of 2026. Together with Polaris’s inclusion in the Russell 1000 ETF, these moves highlight a shift toward refocusing its portfolio and potentially broadening its investor base. Next, we’ll explore how Polaris’s planned divestiture of the Indian motorcycle brand could influence the...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

A Look At Praxis Precision Medicines (PRAX) Valuation After New Driehaus Investment And Recent FDA Filings

Praxis Precision Medicines (PRAX) is back in focus after Driehaus Capital Management committed an additional 432,510 shares, a reported US$80.54 million, alongside fresh FDA submissions for ulixacaltamide and relutrigine. See our latest analysis for Praxis Precision Medicines. The 2.16% 1 day share price return, against a 5.34% 30 day decline and 12.86% 90 day gain, points to choppy but still positive momentum. A very large 1 year total shareholder return above 7x underlines how much...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Is It Time To Reassess eBay (EBAY) After A 43% One Year Share Price Jump

If you are wondering whether eBay's share price still offers value after a strong run, looking closely at what you are paying for the underlying business becomes crucial. The stock last closed at US$90.00, with returns of 3.4% year to date and 42.7% over the past year, while the last 7 days showed a 3.3% decline and the last 30 days a 2.9% gain. Recent headlines have focused on eBay's position in the broader e commerce space and how it is refining its marketplace model to stay relevant with...
NYSE:SGHC
NYSE:SGHCHospitality

A Look At Super Group (NYSE:SGHC) Valuation After Earnings Call Highlights Growth, Cash Generation And Higher Dividends

Super Group (NYSE:SGHC) is back in focus after its latest earnings call highlighted expanding margins, strong cash generation, and a combined US$156 million in shareholder payouts through a special dividend and higher regular dividends. See our latest analysis for Super Group (SGHC). The earnings call lands after a 22.8% 1 month share price return, even though the year to date share price return is still a 6.5% decline. Meanwhile, the 1 year total shareholder return of 73.8% suggests momentum...
NYSE:CAVA
NYSE:CAVAHospitality

CAVA Pushes Into Ohio As Midwest Growth Tests 1,000 Store Goal

CAVA Group (NYSE:CAVA) has opened its first Ohio restaurant in Cincinnati, extending its presence in the Midwest. The company is using its Ohio entry as part of a broader regional build out that supports its goal of reaching 500 locations in the near term. CAVA has outlined a long term ambition to operate 1,000 restaurants across the United States by 2032. CAVA Group, trading at $80.35, is using this Midwest push to grow its national footprint and add new markets beyond its existing core...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Assessing Phillips Edison (PECO) Valuation As Shares Trade Near Analyst Targets

Why Phillips Edison (PECO) is on investors’ radar Phillips Edison (PECO) has drawn attention after recent trading, with shares closing at $38.28 and showing mixed short term returns. This has raised questions about how its current valuation lines up with its fundamentals. See our latest analysis for Phillips Edison. While the 1 day and 7 day share price returns for Phillips Edison have been slightly negative, the 90 day share price return of 9.22% and 1 year total shareholder return of 15.26%...
NYSE:PRI
NYSE:PRIInsurance

Primerica Insider Sales Pattern Raises Questions On Growth Story And Value

Primerica (NYSE:PRI) President Peter Schneider recently sold 1,800 shares of company stock. The transaction adds to a pattern of insider sales at Primerica, with no insider purchases reported over the past year. The sale comes with the stock last closing at $249.06, drawing attention to management’s trading activity. For a company like Primerica, where many investors pay close attention to management alignment, repeated insider selling can stand out. The stock last closed at $249.06, with...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Is Clearway Energy’s (CWEN.A) Share-Class Merger a Quiet Shift in Its Capital Allocation Story?

In March 2026, Clearway Energy, Inc. received board approval to seek shareholder consent to amend its charter and automatically convert each share of its Class A common stock into one share of Class C common stock, consolidating its public equity into a single share class after the 2026 annual meeting. The move is designed to simplify Clearway’s capital structure by eliminating the less liquid Class A line, potentially improving trading liquidity, broadening the investor base, and better...
NYSE:MAC
NYSE:MACRetail REITs

Is Macerich (MAC) Still Attractive After Recent Share Price Weakness And DCF Upside?

If you are wondering whether Macerich at around US$18.66 is offering real value today, or if the easy gains are already on the table, this article will walk through what the current price actually implies. The stock has seen a 5.8% decline over the last 7 days and a 3.7% decline over 30 days, yet it still shows a 0.8% return year to date and an 18.6% return over 1 year, with a very large 3 year return and a 73.9% return over 5 years. Recent moves in Macerich's share price come against a...